EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Carrageenan as a Potential Factor of Inflammatory Bowel Diseases

Paulina Komisarska, Anan Pinyosinwat, Mutaz Saleem, Małgorzata Szczuko iD

Nutrients · 30.04.2024 · 16 (9) · 1367

DOI: 10.3390/nu16091367 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 30.04.2024. Verfasst von Paulina Komisarska und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Nutrition and Metabolomics, Pomeranian Medical University, 71-460 Szczecin, Poland. Hauptthemen laut MEDLINE: Carrageenan, Gastrointestinal Microbiome, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Carrageenan is a widely used food additive and is seen as a potential candidate in the pharmaceutical industry. However, there are two faces to carrageenan that allows it to be used positively for therapeutic purposes. Carrageenan can be used to create edible films and for encapsulating drugs, and there is also interest in the use of carrageenan for food printing. Carrageenan is a naturally occurring polysaccharide gum. Depending on the type of carrageenan, it is used in regulating the composition of intestinal microflora, including the increase in the population of Bifidobacterium bacteria. On the other hand, the studies have demonstrated the harmfulness of carrageenan in animal and human models, indicating a direct link between diet and intestinal inflammatory states. Carrageenan changes the intestinal microflora, especially Akkermansia muciniphilia, degrades the mucous barrier and breaks down the mucous barrier, causing an inflammatory reaction. It directly affects epithelial cells by activating the pro-inflammatory nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) pathway. The mechanism is based on activation of the TLR4 receptor, alterations in macrophage activity, production of proinflammatory cytokines and activation of innate immune pathways. Carrageenan increases the content of Bacteroidetes bacteria, also causing a reduction in the number of short chain fatty acid (SCFA)-producing bacteria. The result is damage to the integrity of the intestinal membrane and reduction of the mucin layer. The group most exposed to the harmful effects of carrageenan are people suffering from intestinal inflammation, including Crohn disease (CD) and ulcerative colitis (UC).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarrageenanGastrointestinal MicrobiomeInflammatory Bowel DiseasesHumansAnimalsAkkermansiaIntestinal Mucosa

Stichwörter der Autor:innen

Crohn’s diseasecarrageenaninflammatory bowel diseasesulcerative colitis

Substanzen

Carrageenan

Autor:innen und Institutionen

  • Department of Human Nutrition and Metabolomics, Pomeranian Medical University, 71-460 Szczecin, Poland.

ORCID-Profile: Małgorzata Szczuko

Zitieren

APA

Komisarska, P., Pinyosinwat, A., Saleem, M., & Szczuko, M. (2024). Carrageenan as a Potential Factor of Inflammatory Bowel Diseases. Nutrients, 16(9), 1367. https://doi.org/10.3390/nu16091367

Vancouver

Komisarska P, Pinyosinwat A, Saleem M, Szczuko M. Carrageenan as a Potential Factor of Inflammatory Bowel Diseases. Nutrients. 2024;16(9):1367. doi:10.3390/nu16091367

BibTeX
@article{Komisarska2024,
  author = {Komisarska, Paulina and Pinyosinwat, Anan and Saleem, Mutaz and Szczuko, Małgorzata},
  title = {Carrageenan as a Potential Factor of Inflammatory Bowel Diseases},
  journal = {Nutrients},
  year = {2024},
  volume = {16},
  number = {9},
  pages = {1367},
  doi = {10.3390/nu16091367}
}
Kostenlos starten →